Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-FR Version v6-FR
Language French French
Date Updated 2022-12-05 2022-12-05
Drug Identification Number 02288184 02288184
Brand name APO-ONDANSETRON APO-ONDANSETRON
Common or Proper name ONDANSETRON ONDANSETRON
Company Name APOTEX INC APOTEX INC
Ingredients ONDANSETRON ONDANSETRON
Strength(s) 4MG 4MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 30 BTL and 10 BLS 30 BTL and 10 BLS
ATC code A04AA A04AA
ATC description ANTIEMETICS AND ANTINAUSEANTS ANTIEMETICS AND ANTINAUSEANTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-11-01 2022-11-01
Estimated end date 2022-12-09 2022-12-09
Actual end date 2022-12-02 2022-12-02
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments
Health Canada comments